Varex Imaging Corporation (VREX) Misses Q1 EPS by 4c

Varex Imaging Corporation (NASDAQ: VREX) reported Q1 EPS of $0.21, $0.04 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $200 million versus the consensus estimate of $189.87 million.

“We had strong revenue growth in the first quarter driven by higher global sales of CT tubes and products for oncology, dental and airport baggage screening applications. Partially offsetting this were lower sales of radiographic digital detectors and mammography products,” said Sunny Sanyal, Chief Executive Officer of Varex. “Since the start of this fiscal year, we have renewed a number of multi-year pricing agreements with key customers, including our largest customer Canon Medical Systems Corporation,” said Sanyal.

For earnings history and earnings-related data on Varex Imaging Corporation (VREX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Pfizer lung cancer drug misses survival goal in Phase 3 trial